Results 71 to 80 of about 30,729 (226)
Toxicity of Bupropion Overdose Compared With Selective Serotonin Reuptake Inhibitors
Pediatrics, 2019 Fluoxetine and escitalopram are FDA-approved prescription medications for pediatric depression but are not the only agents used. We examine adolescent overdose risks of bupropion and SSRIs.
A. Overberg +3 more
semanticscholar +1 more source
Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Amir Jazayeri, Jeannie S. Huang
wiley +1 more source
Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?
British Journal of Pharmacology, EarlyView.Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli +7 more
wiley +1 more source
Bupropion extended-release induced spontaneous orgasms [PDF]
Düşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi, 2014 Sexual side effects are common with antidepressant use. Spontaneous orgasms have been previously described with several antidepressants. We report the case of a woman who had spontaneous orgasms after starting 300mg/day bupropion extended-release ...
mehmet hamdi orum +2 more
doaj
Acute dystonia after single dose of bupropion
Indian Journal of Psychological Medicine, 2016 Bupropion is an antidepressant that is effective in the treatment of major depressive disorders, smoking cessation, and sexual side effects of selective serotonin reuptake inhibitors.
Forouzan Elyasi, Elham Mahtiyan
doaj +1 more source
Brain, behavior, and immunity, 2017 Background Interleukin 17 (IL-17) is produced by highly inflammatory Th17 cells and has been implicated in pathophysiology of depression. IL-17 putatively disrupts the blood brain barrier and affects dopamine synthesis whereas dopamine has been shown to ...
M. Jha +5 more
semanticscholar +1 more source
Novel approaches for drug development against chronic primary pain: A systematic review
British Journal of Pharmacology, EarlyView.Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus +5 more
wiley +1 more source
British Journal of Pharmacology, EarlyView.Abstract Opioids are prescribed widely for chronic pain despite well‐recognised risks and variable long‐term benefit, reflecting the lack of effective alternatives for many patients. Combination therapies offer a promising strategy to enhance efficacy whilst reducing side effects.
André Mouraux +26 more
wiley +1 more source
Annals of General Psychiatry, 2008 Background It is not known if there is a relationship between input rate and incidence of bupropion-induced seizures. This is important, since different controlled release formulations of bupropion release the active drug at different rates.
Fleming Rosanna +4 more
doaj +1 more source
Clinical Psychopharmacology and Neuroscience, 2017 Objective Several studies have suggested the efficacy of bupropion and escitalopram on reducing the excessive internet game play. We hypothesized that both bupropion and escitalopram would be effective on reducing the severity of depressive symptoms and ...
Beomwoo Nam +4 more
semanticscholar +1 more source